论文部分内容阅读
对61例急性髓性白血病（AML）在HOAP方案第一疗程化疗第6天骨髓象作前瞻性观察。发现此时限骨髓白血病原始细胞百分率＜40％并骨髓白血病原始细胞降低指数＞50的病例完全缓解（CR）率达80．6％（25／31例），以上指标一项或二项不符合者仅11．1％（3／27例）病例CR（P＜0．001）。表明本法可较早地预测HOAP方案治疗AML的效果。
61 cases of acute myeloid leukemia (AML) were prospectively observed on the 6th day of the first course of chemotherapy with HOAP. The complete remission (CR) rate of 80.6% (25/31 cases) was found in cases with myeloproliferative myelomonocytic leukemia cells <40% and myeloid leukemia blast cell declining index >50. One or two of the above indicators were not met. Only 11.1% (3/27 cases) of cases had CR (P < 0.001). It shows that this method can predict the effect of HOAP treatment on AML earlier.